CSS
CRBP icon

Cubist Systematic Strategies’s Corbus Pharmaceuticals CRBP Stock Holding History

Cubist Systematic Strategies’s Portfolio CRBP Stock Details CRBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,230
Closed -$68K – 2981
2021
Q2 		$68K Sell
1,230
-2,089
-63% -$116K ﹤0.01% 2760
2021
Q1 		$196K Buy
+3,319
New +$218K ﹤0.01% 2483
2020
Q4 		– Sell
-418
Closed -$23K – 2582
2020
Q3 		$23K Sell
418
-1,065
-72% -$193K ﹤0.01% 2408
2020
Q2 		$373K Buy
+1,483
New +$300K 0.01% 1739

Other funds holding CRBP

EMG
ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $299B AUM 28.69% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Cubist Systematic Strategies's CRBP Position: Q3 2021 in Review

Cubist Systematic Strategies sold out of Corbus Pharmaceuticals (CRBP) in Q3 2021, closing a stake of 1,230 shares — an estimated $68K sold.

Cubist Systematic Strategies first reported a position in CRBP in Q2 2020 and held it in 4 quarters. The position peaked at $373K in Q2 2020. 85 funds tracked by Wall St. Rank hold CRBP as of Q3 2021.

  • Cubist Systematic Strategies reported no remaining Corbus Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Cubist Systematic Strategies sold 1,230 Corbus Pharmaceuticals shares in Q3 2021, an estimated $68K.
  • Cubist Systematic Strategies first reported a position in Corbus Pharmaceuticals in Q2 2020 and held it in 4 quarters.
  • Cubist Systematic Strategies's Corbus Pharmaceuticals position peaked at $373K in Q2 2020.
  • 85 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q3 2021.

Based on Cubist Systematic Strategies's 13F filing for Q3 2021, filed 15 Nov 2021.